Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Apple
AAPL
|
+$564M |
| 3 |
Amazon
AMZN
|
+$486M |
| 4 |
Meta Platforms (Facebook)
META
|
+$331M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$1.88B |
| 2 |
Alibaba
BABA
|
+$1.21B |
| 3 |
Home Depot
HD
|
+$320M |
| 4 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$274M |
| 5 |
FLIR
FLIR Systems, Inc. (DE) Common Stock
FLIR
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.98% |
| 2 | Financials | 13.87% |
| 3 | Healthcare | 13.39% |
| 4 | Consumer Discretionary | 11.81% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SMMF
3051
DELISTED
Summit Financial Group, Inc.
SMMF
| $3.88M | ﹤0.01% |
176,131
+10,196
| +6% | +$250K |
|
|
APR
3052
DELISTED
Apria, Inc. Common Stock
APR
| $3.87M | ﹤0.01% |
138,142
+13,144
| +11% | +$386K |
|
3053
Unilever
UL
$138B
| $3.85M | ﹤0.01% |
58,530
+4,633
| +9% | +$308K |
|
|
BCEL
3054
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $3.83M | ﹤0.01% |
449,553
-5,659
| -1% | -$58K |
|
|
VOXX
3055
DELISTED
VOXX International Corporation Class A
VOXX
| $3.83M | ﹤0.01% |
273,333
-29,490
| -10% | -$478K |
|
|
CDAK
3056
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
| $3.83M | ﹤0.01% |
206,577
+82,905
| +67% | +$1.59M |
|
|
HBMD
3057
DELISTED
Howard Bancorp, Inc. Common Stock
HBMD
| $3.81M | ﹤0.01% |
235,909
+16,447
| +7% | +$272K |
|
3058
Tilray
TLRY
$651M
| $3.79M | ﹤0.01% |
20,976
+5,593
| +36% | +$981K |
|
|
EMWP
3059
DELISTED
Eros Media World PLC
EMWP
| $3.79M | ﹤0.01% |
123,883
+61,115
| +97% | +$1.67M |
|
|
SOLY
3060
DELISTED
Soliton, Inc.
SOLY
| $3.78M | ﹤0.01% |
168,255
+20,395
| +14% | +$412K |
|
3061
Bassett Furniture
BSET
$165M
| $3.78M | ﹤0.01% |
155,308
+73,440
| +90% | +$2.15M |
|
3062
Outlook Therapeutics
OTLK
$176M
| $3.77M | ﹤0.01% |
75,804
+38,720
| +104% | +$1.8M |
|
3063
Ceco Environmental
CECO
$3.95B
| $3.77M | ﹤0.01% |
527,105
+34,783
| +7% | +$269K |
|
|
PSTX
3064
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $3.77M | ﹤0.01% |
376,544
-26,249
| -7% | -$235K |
|
|
GHL
3065
DELISTED
Greenhill & Co., Inc.
GHL
| $3.77M | ﹤0.01% |
242,259
+16,725
| +7% | +$278K |
|
3066
Prudential
PUK
$37.3B
| $3.75M | ﹤0.01% |
101,581
+1,928
| +2% | +$78.9K |
|
3067
Escalade
ESCA
$287M
| $3.75M | ﹤0.01% |
163,267
+10,432
| +7% | +$239K |
|
3068
Fulcrum Therapeutics
FULC
$280M
| $3.74M | ﹤0.01% |
356,592
+71,855
| +25% | +$726K |
|
3069
SSR Mining
SSRM
$5.49B
| $3.73M | ﹤0.01% |
238,955
-359,421
| -60% | -$6.04M |
|
|
KG
3070
Kestrel Group
KG
$71M
| $3.72M | ﹤0.01% |
55,242
+28,569
| +107% | +$1.99M |
|
|
NMTR
3071
DELISTED
9 Meters Biopharma
NMTR
| $3.71M | ﹤0.01% |
168,675
+103,218
| +158% | +$2.53M |
|
3072
RLX Technology
RLX
$2.44B
| $3.71M | ﹤0.01% |
428,645
+75,275
| +21% | +$769K |
|
3073
The ONE Group
STKS
$57.1M
| $3.7M | ﹤0.01% |
336,072
+179,831
| +115% | +$1.82M |
|
3074
South Plains Financial
SPFI
$845M
| $3.69M | ﹤0.01% |
159,489
+15,948
| +11% | +$366K |
|
|
SURF
3075
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $3.68M | ﹤0.01% |
493,021
+318,084
| +182% | +$2.45M |
|
Similar funds
Geode Capital Management's Q2 2021 Portfolio in Review
As of Q2 2021, Geode Capital Management held 4,790 positions worth $726B, up 11% from $654B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Geode Capital Management's Q2 2021 filing shows 331 new, 3,384 increased, 720 reduced and 74 closed positions. Its largest new stake was Organon & Co: 5,070,121 shares worth $153M. The largest sale was Sherwin-Williams, an estimated $1.88B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q2 2021 buy was Organon & Co: 5,070,121 shares worth $153M.
- Geode Capital Management added most to Microsoft in Q2 2021, an estimated $786M increase.
- Geode Capital Management's biggest Q2 2021 reduction was Sherwin-Williams, cutting an estimated $1.88B.
- Geode Capital Management fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $274M.
- Geode Capital Management's ten largest holdings make up 22% of its $726B portfolio in Q2 2021.
- Geode Capital Management opened 331 new positions and closed 74 in Q2 2021.
- Geode Capital Management's portfolio value rose 11% quarter-over-quarter to $726B.
Based on Geode Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.